Somatostatin enhances visual processing and perception by suppressing excitatory inputs to parvalbumin-positive interneurons in V1.
Journal
Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
received:
07
08
2019
accepted:
03
02
2020
entrez:
5
6
2020
pubmed:
5
6
2020
medline:
5
6
2020
Statut:
epublish
Résumé
Somatostatin (SST) is a neuropeptide expressed in a major subtype of GABAergic interneurons in the cortex. Despite abundant expression of SST and its receptors, their modulatory function in cortical processing remains unclear. Here, we found that SST application in the primary visual cortex (V1) improves visual discrimination in freely moving mice and enhances orientation selectivity of V1 neurons. We also found that SST reduced excitatory synaptic transmission to parvalbumin-positive (PV
Identifiants
pubmed: 32494634
doi: 10.1126/sciadv.aaz0517
pii: aaz0517
pmc: PMC7176413
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
eaaz0517Informations de copyright
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).
Références
Neuron. 2018 Jan 3;97(1):83-91.e5
pubmed: 29249287
Nat Neurosci. 2015 Aug;18(8):1116-22
pubmed: 26167904
Mol Cell Endocrinol. 2008 May 14;286(1-2):96-103
pubmed: 18221832
Cereb Cortex. 2008 Jul;18(7):1575-87
pubmed: 18203698
Nature. 2012 Aug 16;488(7411):379-83
pubmed: 22878719
J Neurophysiol. 2012 Jun;107(11):3116-34
pubmed: 22402650
Nat Neurosci. 2005 Feb;8(2):173-8
pubmed: 15643430
Nat Neurosci. 2013 Aug;16(8):1068-76
pubmed: 23817549
Neuropsychologia. 2009 Oct;47(12):2574-83
pubmed: 19450614
Psychoneuroendocrinology. 1984;9(3):233-48
pubmed: 6149588
J Physiol Paris. 2000 May-Aug;94(3-4):259-64
pubmed: 11088003
J Comp Neurol. 2002 Jan 28;443(1):1-14
pubmed: 11793343
Prog Neurobiol. 1986;27(1):63-100
pubmed: 2874591
Front Neural Circuits. 2016 Jun 30;10:48
pubmed: 27445703
Front Neuroanat. 2018 Jul 23;12:59
pubmed: 30083094
J Neurosci. 1996 Jul 15;16(14):4468-78
pubmed: 8699257
Front Neuroanat. 2018 Nov 06;12:88
pubmed: 30459565
Neurochem Res. 2008 Aug;33(8):1452-8
pubmed: 18270823
Nature. 2014 Apr 3;508(7494):E1-2
pubmed: 24695313
PLoS One. 2012;7(6):e38011
pubmed: 22723842
Neuropharmacology. 2004 Mar;46(3):388-96
pubmed: 14975694
Nature. 2012 Oct 11;490(7419):226-31
pubmed: 23060193
Neuroscience. 1997 Jan;76(1):225-40
pubmed: 8971774
Nature. 1980 Nov 20;288(5788):279-80
pubmed: 6107862
Neuron. 2014 Jan 8;81(1):179-94
pubmed: 24361077
Nature. 1996 May 16;381(6579):242-5
pubmed: 8622767
Naunyn Schmiedebergs Arch Pharmacol. 2003 Jun;367(6):562-71
pubmed: 12759718
J Neurosci. 1983 Jun;3(6):1176-88
pubmed: 6133919
Neuroscience. 1991;41(2-3):595-606
pubmed: 1678505
Science. 1973 Jan 5;179(4068):77-9
pubmed: 4682131
Proc Natl Acad Sci U S A. 1986 Oct;83(19):7518-21
pubmed: 2876428
J Neurosci Methods. 2006 Sep 15;155(2):207-16
pubmed: 16580733
Br J Pharmacol. 1998 May;124(1):252-8
pubmed: 9630367
Trends Neurosci. 2004 Mar;27(3):135-42
pubmed: 15036878
Neuroscience. 2000;98(3):513-22
pubmed: 10869845
J Cell Biol. 2008 Feb 11;180(3):483-91
pubmed: 18250196
Neuron. 2016 Nov 23;92(4):902-915
pubmed: 27746132
Neuron. 2012 Jan 12;73(1):159-70
pubmed: 22243754
Nature. 2012 Aug 16;488(7411):343-8
pubmed: 22878717
Nature. 2018 Nov;563(7729):72-78
pubmed: 30382198